Talk Trial Design and Protocol Development track
The Protocol That Almost Wrote Itself—How AI Transforms Study Design, Protocol Digitisation, and Clinical Document Authoring
Wed, Oct 14, 2026 · 1:55–2:20 PM CEST InterContinental Barcelona
About this session
Sponsored by Evinova. The protocol is the single most consequential document in any clinical programme, yet it's too often treated as a static PDF rather than a structured digital asset. This interactive session brings together pharma leaders and technical experts to explore three concrete ways AI is reshaping the protocol lifecycle: Mining the past—Turning decades of trial history into a queryable knowledge Designing before committing—Using simulation and real-world data to stress-test eligibility criteria and enrolment assumptions Authoring beyond the protocol—Generating and maintaining consistency across downstream documents (ICF, SAP, eCRF) as the protocol evolves Rather than a technology showcase, this is a working conversation: panelists share where AI is already delivering value, and attendees are invited to weigh in on where their own organisations stand—and what's really holding transformation back.
Speakers
-
Senior Commercial Director, AI Enabled Clinical Development · Evinova
Speaker
-
Director, Data Science · Evinova
Speaker
-
Senior Director, Head of Data Strategy & Products, Global Functions · Johnson & Johnson Innovative Medicine
Speaker
-
Head of Protocol Excellence, Clinical Science · Daiichi Sankyo
Speaker
-
Medical Director, Early Global Dev, Oncology R&D · AstraZeneca
Speaker
Reviews of this session
No reviews yet
Were you in the room? Reviews are open until Oct 14, 2027.